Beijing Beilu Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Beijing Beilu Pharmaceutical has a total shareholder equity of CN¥1.8B and total debt of CN¥836.4M, which brings its debt-to-equity ratio to 46.5%. Its total assets and total liabilities are CN¥2.9B and CN¥1.1B respectively.
Key information
46.5%
Debt to equity ratio
CN¥836.37m
Debt
Interest coverage ratio | n/a |
Cash | CN¥802.18m |
Equity | CN¥1.80b |
Total liabilities | CN¥1.07b |
Total assets | CN¥2.87b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300016's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥368.0M).
Long Term Liabilities: 300016's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥702.5M).
Debt to Equity History and Analysis
Debt Level: 300016's net debt to equity ratio (1.9%) is considered satisfactory.
Reducing Debt: 300016's debt to equity ratio has increased from 0% to 46.5% over the past 5 years.
Debt Coverage: 300016's debt is not well covered by operating cash flow (6.9%).
Interest Coverage: Insufficient data to determine if 300016's interest payments on its debt are well covered by EBIT.